Masimo Corporation: Expansion into Consumer Health Products

Masimo Corporation reported its fourth quarter and full-year 2024 financial results, highlighting both accomplishments and areas that require attention. On the positive side, the company exhibited solid performance with consolidated revenues for the fourth quarter reaching $601 million, representing a 9% increase on a constant currency basis. Healthcare revenues grew by 9% to $368 million, which was bolstered by the shipment of 65,000 technology boards and monitors, reaching the high end of expectations. For the non-healthcare segment, revenues increased by 11% to $232 million. The company also demonstrated robust operational efficiency, with a consolidated gross margin of 52%,
including a 63% margin for healthcare and 35% for non-healthcare.